Howard Horn Ultragenyx Pharmaceutical Inc. (RARE) insider trading activity

Howard Horn is Chief Financial Officer of Ultragenyx Pharmaceutical Inc.. Currently has a direct ownership of 91,996 shares of RARE, which is worth approximately $3.04 Million. The most recent transaction as insider was on Jan 02, 2026, when has been sold 3,150 shares (Common Stock) at a price of $22.84 per share, resulting in proceeds of $71,946. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 92K

13.35% 3M change

0.33% 12M change

Total Value Held $3.04 Million

Howard Horn Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 02 2026	SELL Open market or private sale	$71,946 $22.84 p/Share	3,150 Reduced 3.31%	91,996 Common Stock
Dec 10 2025	SELL Open market or private sale	$112,086 $36.38 p/Share	3,081 Reduced 3.14%	95,146 Common Stock
Oct 13 2025	SELL Open market or private sale	$250,252 $31.51 p/Share	7,942 Reduced 7.48%	98,227 Common Stock
Mar 06 2025	SELL Open market or private sale	$72,114 $40.4 p/Share	1,785 Reduced 1.65%	106,169 Common Stock
Mar 01 2025	BUY Grant, award, or other acquisition	-	15,653 Added 12.66%	107,954 Common Stock
Oct 10 2024	SELL Open market or private sale	$393,853 $52.76 p/Share	7,465 Reduced 7.48%	92,301 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	19,400 Added 16.28%	99,766 Common Stock

Oct 09 2023	BUY Grant, award, or other acquisition	-	80,366 Added 50.01%	80,336 Common Stock

Also insider at

VIR

Vir Biotechnology, Inc. Healthcare

CFO

Howard Horn

Chief Financial Officer

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RARE shares.

Notify only if

Value

Insider Trading

Get notified when an Ultragenyx Pharmaceutical Inc. insider buys or sells RARE shares.

Notify only if

Operation

Value

Type

News

Receive news related to Ultragenyx Pharmaceutical Inc.

Track Activities on RARE

Account